Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FBGU6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,101
Award facts
- Contract value 100% obligated
- $42,101.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Vraylar 1.5 mg capsules (30-count packaging) under a firm fixed-price contract valued at $42,101.15, with completion scheduled for September 2, 2025. This non-set-aside competitive award is classified as a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations for federal pharmaceutical procurement.
This delivery order represents a routine pharmaceutical procurement through AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which operates through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. Vraylar, a neuropsychiatric medication, is among the specialized pharmaceutical products the contractor supplies to support Defense Health Agency operations and other federal healthcare customers. The transaction reflects AmerisourceBergen's ongoing role as a critical vendor within the federal medical supply chain, fulfilling routine pharmaceutical needs across multiple therapeutic domains for military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FBGU6?
SPE2DB25FBGU6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FBGU6 worth?
The government has obligated $42,101 on SPE2DB25FBGU6.
Is contract SPE2DB25FBGU6 an order under another contract?
Yes. SPE2DB25FBGU6 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBGU6 competed?
The extent of competition for SPE2DB25FBGU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award